{"changes":[],"country":"US","description":"Abzyme Therapeutics develops modular single-domain VHH antibody fragments for immunotherapy using a proprietary yeast-display discovery platform. It serves biopharma partners needing antibodies optimized for affinity, solubility, and developability. Its differentiator is a self-diversifying library that screens these properties in real time.","domain":"abzymetx.com","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"healthtech","investors":[],"lat":40.245298,"lng":-75.649642,"location":"Pottstown, Pennsylvania, USA","name":"ABZYME THERAPEUTICS LLC","rounds":[{"amountQuarantined":false,"amountUsd":1657994,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-06","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"abzymetx-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-06","status":"attributed","url":null},{"fact":"existence","publisher":"abzymetx.com","retrievedAt":"2026-05-06","status":"self-reported","url":"https://abzymetx.com"},{"fact":"description","publisher":"abzymetx.com","retrievedAt":"2026-05-06","status":"self-reported","url":"https://abzymetx.com"}],"stage":null,"techStack":["Cloudflare","WordPress","Genesis theme","Slider Revolution 6.7.55","jQuery Migrate 3.4.1","WP Rocket","PHP","MySQL","jquery 3."],"totalRaisedUsd":1657994,"updatedAt":"2026-05-06"}